NCT00301600View on ClinicalTrials.gov

Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

January 31, 2006

Conditions
IGA Nephropathy
Interventions
DRUG

Mycophenolate mofetil

MMF,1.0g/d

Trial Locations (1)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER

NCT00301600 - Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy | Biotech Hunter | Biotech Hunter